Articles & Video
BioProcess International Spring Digital Week 2020 agenda revealed
We reveal the sessions of the upcoming 7-day webinar series on innovating biopharmaceutical development and production.
BioProcess International | BioProcess Insider
BioProcess International is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics.
Antibody Engineering & Therapeutics Digital Week 2020 agenda revealed
We take a look at the session line-up for the upcoming webcast series exploring the latest insights, trends and technologies for optimizing next generation antibodies.
Looking to 2030 Report: The Future of the Global Life Sciences and Pharma Industry
This exclusive report looks at predictions for how the global life sciences and pharma industry will change over the coming decade.
COVID-19 antibody therapeutic development - WHITEPAPER
This paper evaluates the antibody therapies for COVID-19 currently in clinical trials and preclinical development.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Antibody Engineering and Therapeutics Survey: Tell us your views
Take part in our huge antibody therapeutic modalities survey to be in with a chance of winning a free conference pass.
The Future of Antibody Engineering and Therapeutics - eBook Series
In the first of our Antibody Therapeutics eBook Series, we take an in-depth look at how the latest technologies and strategies are shaping the future of the industry.
BioProcessing Bites: the mini webinar series on bioprocess innovation
We take a look at the first in a series of live mini webinars exporing biopharmaceutical development and production, coming May 5.
Emerging Therapies Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
Manufacturing oligonucleotides: addressing safety and delivery challenges
We explore ways to tackle the main challenges in designing control strategies for oligonucleotide therapeutics.
Standardisation and Opportunities in Manufacturing Microbiome Therapeutics- WHITEPAPER
This whitepaper identifies the challenges and opportunities in defining manufacturing standards for microbiome therapeutics.
Creating novel cell lines by genome editing
Applied to cell lines, genome editing could improve their efficiency and help devise novel assays to find new bioactive molecules
Are standards for manufacturing microbiome therapeutics really far off? - INDUSTRY VOICES
Five experts in microbiome therapeutics tell us how close they see the industry to defining manufacturing standards.
Speed to IND: Balancing risk and reward
This eBook records an interview with Susan Dana Jones (Harpoon Therapeutics) about balancing speed to IND without leaving gaps in process understanding and scalability.
Formulation development of microbiome therapeutics localized in the intestines
What are the challenges and possible solutions for localized intestinal delivery of microbiome therapeutics?
Next Gen protein drug challenges and the latest technologies to overcome them - WHITEPAPER
This whitepaper looks at the main challenges facing protein-based therapeutics and the innovative new technologies and methods are being used to overcome them.
Measure Twice, Treat Once: Navigating the regulatory landscape of assay development to ensure high-quality CGT products
In this article from BioProcess International, the authors discuss the use of analytical assays in process development and manufacturing of cell and gene therapeutics.
Autologous cell therapies: Commercialization strategies
This BioProcess International eBook looks at commercialization strategies for autologous cell therapies.
Insourcing vs outsourcing in cell and gene therapy manufacturing - WHITEPAPER
This whitepaper presents best practices for planning an outsourcing or insourcing strategy for manufacturing cell and gene therapies.